The Paul and Diane Manning Institute of Biotechnology
About The Paul and Diane Manning Institute of Biotechnology
The Paul and Diane Manning Institute of Biotechnology engages in the medical research that leads to new medical treatments, including cellular therapy, gene therapy, nanotechnology and drug delivery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $300.0M
- Last round: Grant (Jan 2023)
- Website: manninginstitute.virginia.edu
Industries & Categories
Health Care, Medical, Nanotechnology, Therapeutics
Canonical: https://fsome.com/organization/the-paul-and-diane-manning-institute-of-biotechnology-64147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.